Solid Biosciences (SLDB) EBT: 2017-2024
Historic EBT for Solid Biosciences (SLDB) over the last 7 years, with Dec 2024 value amounting to -$38.0 million.
- Solid Biosciences' EBT fell 84.64% to -$38.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$120.6 million, marking a year-over-year decrease of 24.19%. This contributed to the annual value of -$120.6 million for FY2024, which is 24.19% down from last year.
- As of Q4 2024, Solid Biosciences' EBT stood at -$38.0 million, which was down 15.51% from -$32.9 million recorded in Q3 2024.
- Over the past 5 years, Solid Biosciences' EBT peaked at -$19.0 million during Q2 2020, and registered a low of -$38.0 million during Q4 2024.
- Over the past 3 years, Solid Biosciences' median EBT value was -$25.3 million (recorded in 2024), while the average stood at -$27.0 million.
- As far as peak fluctuations go, Solid Biosciences' EBT surged by 37.62% in 2023, and later crashed by 84.64% in 2024.
- Quarterly analysis of 4 years shows Solid Biosciences' EBT stood at -$21.4 million in 2020, then reached -$33.0 million in 2022, then spiked by 37.62% to -$20.6 million in 2023, then crashed by 84.64% to -$38.0 million in 2024.
- Its EBT was -$38.0 million in Q4 2024, compared to -$32.9 million in Q3 2024 and -$25.3 million in Q2 2024.